Chinese Pharmaceutical Start-Up Xgene Raises $20M In Series B Round

Login to View

Xgene Pharmaceutical, a Shanghai-based pharmaceutical start-up, has raised US$20 million in series B round of financing led by Ping An Ventures.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in